TCT-411 Risk and timing of clinical events according to diabetic status of patients treated with Everolimus-Eluting Bioresorbable Vascular Scaffolds vs. Everolimus-Eluting stent: 2-Year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials
Campos, Carlos, Abizaid, Alexandre, Caixeta, Adriano, Bartorelli, Antonio, Whitbourn, Robert, Perin, MarcoVolume:
68
Language:
english
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/j.jacc.2016.09.546
Date:
November, 2016
File:
PDF, 150 KB
english, 2016